Osteonecrose mandibular associada ao uso de bisfosfonato de sódio em paciente com mieloma múltiplo
Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial - Tập 55 - Trang 115-120 - 2014
Tài liệu tham khảo
Ruggiero, 2006, Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer, J Oncol Pract, 2, 7, 10.1200/JOP.2.1.7
Ruggiero, 2009, American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate‐Related Osteonecrosis of the Jaws—2009 Update, J Oral Maxillofac Surg, 67, 2
Otto, 2012, Bisphosphonate‐related osteonecrosis of the jaws ‐ Characteristics, risk factors, clinical features, localization and impact on oncological treatment, J Craniomaxillofac Surg, 40, 303, 10.1016/j.jcms.2011.05.003
Berenson, 2002, American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma, J Clin Oncol, 20, 3719, 10.1200/JCO.2002.06.037
Assael, 2009, Oral bisphosphonates as a cause of bisphosphonate‐related osteonecrosis of the jaws: Clinical findings, J Oral Maxillofac Surg, 67, 35, 10.1016/j.joms.2009.01.003
Durie, 2005, Osteonecrosis of the jaw and bisphosphonates, N Engl J Med, 353, 99, 10.1056/NEJM200507073530120
Fournier, 2002, Bisphosphonates inhibit angiogenesis in vitro and testosterone‐stimulated vascular regrowth in the ventral prostate in castrated rats, Cancer Res, 62, 6538
Gallego, 2011, Rubber dam clamp trauma during endodontic treatment: A risk factor of bisphosphonate‐related osteonecrosis of the jaw?, J Oral Maxillofac Surg, 69, 93, 10.1016/j.joms.2010.06.197
Rang, 2004
Martins, 2009, Osteonecrose dos maxilares associada ao uso de bisfosfonatos: importante complicação do tratamento oncológico, Rev Bras Hematol Hemoter, 31, 41, 10.1590/S1516-84842009005000008
Gegler, 2006, Bisfosfonatos e osteonecrose maxilar: revisão da literatura e relato de dois casos, Rev Bras de Cancerologia, 52, 25, 10.32635/2176-9745.RBC.2006v52n1.1904
Marx, 2005, Bisphosphonate‐induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment, J Oral Maxillofac Surg, 63, 1567, 10.1016/j.joms.2005.07.010
Otto, 2010, Bisphosphonate‐related osteonecrosis of the jaw: Is pH the missing part in the pathogenesis puzzle?, J Oral Maxillofac Surg, 68, 1158, 10.1016/j.joms.2009.07.079
Diego, 2007, Bisphosphonate‐associated osteonecrosis of the jaws: A therapeutic dilemma, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103, 1, 10.1016/j.tripleo.2006.09.022
Sousa, 2008, Osteonecrose associada com o uso dos bifosfonatos, Pesq Bras Odontoped Clin Integr, 8, 375, 10.4034/1519.0501.2008.0083.0020
Dotto, 2011, Osteonecrose dos maxilares induzida por bisfosfonatos – revisão de literatura e relato de caso, RFO UPF, 16, 229
Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004
Sarasquete, 2009, Bisphosphonate‐related osteonecrosis: Genetic and acquired risk factors, Oral Dis, 15, 382, 10.1111/j.1601-0825.2009.01568.x
Coelho, 2010, Osteonecrose dos maxilares associada ao uso de bifosfonatos. Parte I: etiologia e apresentação clínica, Rev Port Estomatol Med Dent Cir Maxilofac, 51, 95
Dimopoulos, 2009, Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid, Ann Oncol, 20, 117, 10.1093/annonc/mdn554
Mehrotra, 2008, Outcomes of bisphosphonate related osteonecrosis of the jaw. Importance of staging and management: A large single institution update, J Clin Oncol, 26
Vescovi, 2012, Early surgical laser‐assisted management of bisphosphonate‐related osteonecrosis of the jaws (BRONJ): A retrospective analysis of 101 treated sites with long‐term follow‐up, Photomed Laser Surg, 30, 5, 10.1089/pho.2010.2955
Oliveira, 2013, Low level laser therapy in biphosphonates osteonecrosis of mandibular, Oral Oncol, 49, S134
Curi, 2007, Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet‐rich plasma: Report of 3 cases, J Oral Maxillofac Surg, 65, 349, 10.1016/j.joms.2005.12.051
Harper, 2007, Resolution of bisphosphonate‐associated osteonecrosis of the mandible: Possible application for intermittent low‐dose parathyroid hormone [rhPTH(1‐34)], J Oral Maxillofac Surg, 65, 573, 10.1016/j.joms.2006.10.076
Ruggiero, 2006, Bisphosphonate‐related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, 233, 10.1016/j.tripleo.2006.06.004
Coelho, 2010, Osteonecrose dos maxilares associada ao uso de bifosfonatos. Parte II: linhas de orientação na consulta de medicina dentária, Rev Port Estomatol Med Dent Cir Maxilofac, 51, 185
Ferlito, 2012, Treatment of bisphosphonate‐related osteonecrosis of the jaws: Presentation of a protocol and an observational longitudinal study of an Italian series of cases, Br J Oral Maxillofac Surg, 50, 425, 10.1016/j.bjoms.2011.08.004